Freeman Spogli Institute for International Studies Program on Energy and Sustainable Development Stanford University

News and commentary

Photo of Alan Garber

Alan M. Garber, MD, PhD

Provost of Harvard University, Mallinckrodt Professor of Health Care Policy at Harvard Medical School and a Professor of Economics in the Harvard Kennedy School of Government and the Faculty of Arts and Sciences and Former CHP/PCOR Director; Henry J. Kaiser, Jr. Professor Emeritus

View Alan Garber's bio, list of research, recent publications and events »

Display news from  

July 7th, 2011

The Benefits of Health Insurance for the Poor

FSI Stanford, CHP/PCOR in the news: The New York Times on July 7, 2011

When poor people are given medical insurance, they not only find regular doctors and see doctors more often but they also feel better, are less depressed and are better able to maintain financial stability, according to a new, large-scale study that provides the first rigorously controlled assessment of the impact of Medicaid. Those who do not have health insurance tend to be different in many ways from people who have it, says Alan Garber, MD head of Stanford Health Policy.

May 20th, 2011

Population Reference Bureau interviews Alan Garber


In an interview with the Population Reference Bureau (PRB), Alan Garber discusses cost-effectiveness research and its importance to health care reform. Read more »

April 15th, 2011

Alan Garber named Provost of Harvard

FSI Stanford, CHP/PCOR News

Alan Garber, the Henry J. Kaiser, Jr. Professor and Professor of Medicine and Economics, and Director of Stanford Health Policy (Center for Health Policy/Center for Primary Care and Outcomes Research), has been named Provost of Harvard University, effective fall 2011. Making the announcement Harvard President Drew Faust said, “Alan is a distinguished academic leader who brings to Harvard an extraordinary breadth of experience in research across disciplines." FSI Director Coit D. Blacker, the Olivier Nomellini Professor in International Studies said, "We congratulate Alan on his appointment as Provost of Harvard. We will miss his probing intellect, his contributions to scholarship and public policy, and his keen appreciation of the challenges facing research universities." In a message to colleagues Alan Garber said, "My time on the faculty at Stanford has been wonderful in every important way. The past 13 years, when CHP and PCOR were created and grew, have been the high point of my Stanford career."

February 15th, 2011

The 112th Congress: What's in Store for Cancer Care in 2011?

CHP/PCOR in the news: The ASCO Post

The 111th Congress is gone but not forgotten, having passed into law the landmark Affordable Care Act of 2010. Although this legislation has several interesting appropriations for cancer research, a core principle of the bill is finding ways to reduce health-care spending, which gives the oncology community an uneasy sense of déjà vu: The Medicare Modernization Act of 2003 hammered oncology with deep cuts in reimbursement for Part B drugs, leaving many community infusion centers underwater. Oncology practices, especially smaller one- to three-person groups, have to wonder how much more change they can take. Read more »

April 21st, 2010

IOM recommendations for sodium intake cites SHP study

CHP/PCOR in the news

The Institute of Medicine issued recommendations for decreasing sodium intake in the United States, and drew upon a recent study by Stanford Health Policy trainee Crystal Smith-Spangler, director Alan Garber and core faculty member Douglas Owens. The IOM report referenced their Annals of Internal Medicine paper, which found that a voluntary effort by the U.S. food service industry to reduce salt in processed foods could prevent strokes and heart attacks in nearly a million Americans and saving $32.1 billion in medical costs.

« Earlier news | Most current news articles »»

Select news articles from:

August 2014










































News around the web

Individualized cost-effectiveness analysis useful for clinicians and patients
John Ioannidis and Alan Garber from Stanford University, USA, discuss how to use incremental cost-effectiveness ratios (ICER) and related metrics so they can be useful for decision-making at the individual level, whether used by clinicians or individual patients. The authors say that "Cost-effectiveness analysis offers a foundation for rational decision-making and can be very helpful in making health care more efficient and effective at the population level.
July 12, 2011 in EurekAlert (press release)

Stanford's Garber assumes role of Harvard provost
Professor of Medicine Alan Garber MD '83 will sport crimson rather than cardinal this fall as he takes on the role of provost at Harvard University in Cambridge, Mass. In his 25 years at Stanford, Garber has distinguished himself beyond the medical ...
April 18, 2011 in The Stanford Daily

Harvard Names Alan Garber of Stanford as Its Next Provost
Harvard University named Alan Garber, a Stanford University professor of medicine and economics, as its next provost, replacing Steven Hyman, who will step down at the end of the academic year.
April 15, 2011 in Bloomberg

Cancer-vaccine review highlights debate over costs and benefits of pricey ...
(The drug, which was developed at Stanford, was the first-ever cancer vaccine to get the FDA's nod.) Now, the federal government has launched what is being ...
November 8, 2010 in Scope (blog)

New drug may provide more cost-effective stroke prevention than warfarin ...
STANFORD, Calif. — A newly approved drug may be a cost-effective way to prevent stroke in patients with an irregular heart rhythm — and may also offer ...
November 1, 2010 in EurekAlert (press release)

More news around the web »